Singapore-based Clearbridge BioMedics has won three awards at The Asian
Innovation Awards 2012.
Singapore-based Clearbridge
BioMedics has won three awards at The Asian Innovation Awards 2012. The results
were announced on Tuesday in Hong Kong.
The Awards are presented annually
by The Wall Street Journal in partnership with Credit Suisse.
Clearbridge BioMedics took home
the grand prize for The Asian Innovation Awards 2012, which recognizes
innovations that improve quality of life or productivity. It also received the
Credit Suisse Technopreneur of the Year Award, which honors technologies with
the greatest potential for commercial success.
It beat out 11 other finalists
who had been shortlisted from more than 240 applications.
As a bonus, it also won the
Audience Choice Award, which was based on the votes of the audience at the
event.
“Innovation and entrepreneurship
play essential roles in driving economic growth across the Asia-Pacific region.
My congratulations to Clearbridge BioMedics on their ingenuity and success in
this year’s Asian Innovation Awards,” said Mr. Dan Molloy, global executive
director for multimedia sales, Asia, for The Wall Street Journal.
Clearbridge BioMedics began as a
spin-off company from the Faculty of Engineering at the National University of
Singapore.
It is commercializing its
proprietary ClearCell™ System to detect, isolate, and retrieve wholly-intact
circulating tumor cells (CTCs) from small quantities of patient blood samples.
The ClearCell™ System has achieved ISO13485 certification, and is available for
the cancer research market.
“Clearbridge BioMedics is
absolutely delighted and honored to win, not one but three awards, at the Asian
Innovation Awards. We aim to further develop our ClearCell™ System into a
health-care solution that will empower cancer clinicians and researchers to
manage cancer in a more effective manner,” said Mr. Johnson Chen, Founder of
Clearbridge BioMedics.
Source: Clearbridge BioMedicsc.
No comments:
Post a Comment